NKY(SZ:300109)2021-10-26 16:00Revenue and Profit - Revenue for Q3 2021 reached ¥329,067,234.44, an increase of 36.35% compared to the same period last year[3] - Net profit attributable to shareholders decreased by 36.70% to ¥16,606,412.69 in Q3 2021, while year-to-date net profit increased by 30.23% to ¥100,072,481.22[3] - Basic and diluted earnings per share for Q3 2021 were both ¥0.05, down 37.50% year-on-year[3] - Total operating revenue for Q3 2021 reached ¥865,448,525.95, an increase of 26.1% compared to ¥686,239,524.02 in Q3 2020[23] - Net profit for Q3 2021 was ¥95,579,087.42, representing a 30.5% increase from ¥73,217,917.57 in Q3 2020[24] - The net profit attributable to the parent company for Q3 2021 was ¥100,072,481.22, an increase from ¥76,841,972.81 in the same period last year, representing a growth of approximately 30.3%[25] - The total comprehensive income attributable to the parent company for Q3 2021 was ¥98,941,322.59, compared to ¥70,747,124.86 in Q3 2020, marking an increase of about 39.7%[25] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥49,717,011.30, a significant decrease of 71.73%[3] - The net cash flow from operating activities decreased by 71.73% to ¥49,717,011.30, attributed to higher cash payments for goods purchased[7] - Cash inflow from operating activities for Q3 2021 was ¥939,352,078.07, compared to ¥736,521,161.65 in the previous year, indicating an increase of approximately 27.5%[28] - The net cash flow from operating activities decreased to ¥49,717,011.30 in Q3 2021 from ¥175,840,356.58 in Q3 2020, a decline of about 71.7%[28] - Cash flow from investing activities showed a net outflow of ¥50,679,287.96 in Q3 2021, an improvement from a net outflow of ¥84,831,752.77 in the same period last year[30] - Cash flow from financing activities generated a net inflow of ¥28,009,426.30 in Q3 2021, compared to a net outflow of ¥91,801,733.60 in Q3 2020, indicating a significant turnaround[30] Assets and Liabilities - Total assets at the end of Q3 2021 were ¥4,373,190,615.67, reflecting a 5.49% increase from the end of the previous year[3] - Total assets amounted to ¥4,373,190,615.67, an increase from ¥4,145,478,401.96, showing a growth of 5.5%[21] - Total liabilities increased to ¥1,177,008,407.91 from ¥1,069,241,820.16, representing a growth of 10.1%[21] - The company's total liabilities reached approximately CNY 1.07 billion, with current liabilities accounting for about CNY 1.00 billion[35] Shareholder Information - Shareholders' equity attributable to the parent company increased by 4.04% to ¥3,203,121,883.15 compared to the end of the previous year[3] - The total number of ordinary shareholders at the end of the reporting period was 16,073[9] - The top shareholder, Wang Donghu, holds 8.92% of shares, with 30,663,481 shares pledged[10] - A total of 32,306,898 shares will be distributed to shareholders, with a cash dividend of RMB 0.2 per 10 shares, totaling RMB 6,461,379.66[15] Expenses and Income - Management expenses rose by 61.83% to ¥124,597,432.40, primarily due to increased share-based payment expenses[7] - Other income increased by 163.15% to ¥3,214,169.93, mainly due to an increase in government subsidies related to operations[7] - The company reported a significant increase in R&D expenses to ¥57,128,622.73, compared to ¥55,084,646.69 in the previous year, reflecting a growth of 3.7%[24] Investments and Projects - The company transferred 4.1818% equity in Wuhan Feiste Biotechnology Co., Ltd. for RMB 14 million, reducing its stake from 8.1818% to 4%[14] - The investment in the PVP Phase I project in Jiaozuo City is approximately RMB 183 million, with a construction period of about 28 months, aiming for an annual production capacity of 20,000 tons of NVP[14] - The company sold 100% equity of NKYUS to Abcam US for cash, aiming to reduce goodwill and protect the interests of minority shareholders[15] Stock and Equity Incentives - The company plans to grant 28 million restricted stocks at a price of RMB 5.83 per share as part of the 2021 restricted stock incentive plan[14] - The company completed the registration of 20.55 million restricted stocks at a price of RMB 5.81 per share, increasing the total share capital from 323,068,983 to 343,618,983 shares[15] - The company has 31,909,559 shares under lock-up, with 10,819,057 shares released during the reporting period[13] - The company’s total restricted shares at the end of the period amount to 41,916,361 shares[13] - The company’s stock incentive plan includes 313 individuals, with a total of 16,890,000 shares under lock-up[13] Other Financial Information - The company reported goodwill of approximately CNY 2.12 billion, indicating significant intangible assets[34] - The report for the third quarter was not audited, which may affect the reliability of the financial data presented[37]